was difficult to sustain funding. But according to Dr. Barker, nanotechnology is an area of huge investment internationally, especially by venture capital firms. “It is very exciting to all of us to see this level of interest in terms of the financing world, which will make things happen,” she said. In regards to developing nanomedicines that can prevent cancer, Dr. Hawk claimed that there are major concerns by industry that such a venture will not be profitable because of the long time frames needed to conduct the relevant clinical studies, and because they may not be able to patent their discoveries.

The National Academies of Sciences, Engineering, and Medicine
500 Fifth St. N.W. | Washington, D.C. 20001

Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement